3 Stocks I Saw on T...
Health Care: Health Services
Icon PLC (ICLR: NASDAQ)
$20.26 -0.11 | -0.54%
02/09/12 - 04:00 PM ET
93.16K / 215.60K
Vol / Avg. Vol:20.30 / 20.37
Open / Prev. Close:20.19 - 20.51
Today's Range:15.03 - 26.22
52 Wk Range:19.05%
Performance YTD:TheStreet Rating:
Portfolios with ICLR
- Portfolio NameUser Type
- Contributor10 Top Morningstar M&A Stoc...
- UserSUPRATRADE Top 10 Best-Rate...
- UserSUPRATRADE-Top-Performing C...
- UserPART 1 JPMorgan 28th Annual...
- ContributorFast Money's Healthcare Ref...
- UserMMB
- UserPART 1 JPMorgan 27th Annual...
- UserRHM's Stocks
- Userwilliam 1
- Userchuckd72 Portfolio 1
Latest ICLR Headlines from TheStreet
- 10 Top Morningstar M&A Stock Picks for 2012 01.20.12 | 01:01 pm
- 3 Stocks I Saw on TV
07.02.09 | 08:07 am - 'Fast Money' Recap: Will Oil Kill the Rally? 07.01.09 | 07:07 pm
- A Safer Way to Play the Drug Sector 02.26.08 | 06:02 am
- Thursday's Health Winners & Losers 02.21.08 | 04:02 pm
- Wednesday's Health Winners & Losers 12.19.07 | 03:12 pm
- Friday's Health Winners & Losers 08.18.06 | 03:08 pm
- Health Stocks in Motion 01.06.05 | 04:01 pm
Press Releases for ICLR
- ICON Selected By Shire Plc’s Specialty Pharmaceuticals Division As Global Strategic Partner For Clinical Research And Central Laboratory Services - Business Wire 01.09.12 | 02:01 am
- ICON Announces Dr. Anthony Murphy To Retire From Board Of Directors - Business Wire 12.27.11 | 05:12 am
- ICON Acquires BeijingWits Medical Consulting Ltd - Business Wire 12.12.11 | 05:12 am
- Tasly Pharmaceuticals Selects ICON As It Seeks First FDA Approval Of A Traditional Chinese Medicine - Business Wire 11.21.11 | 05:11 am
- ICON Reports Q3 Revenue Growth Of 7% To $241 Million And Net New Business Of $431 Million. (NASDAQ:ICLR) (ISIN:IE0005711209) - Business Wire 10.27.11 | 06:10 am
- ICON Announces Peter Gray To Retire As CEO - Business Wire 09.07.11 | 06:09 am
- ICON Selected As A Preferred Provider For Early Phase Clinical Development By Bristol-Myers Squibb - Business Wire 08.30.11 | 06:08 am
- ICON Reports Second Quarter 2011 Net New Business Of $310 Million, Revenue Of $233 Million And EPS Of 21c (NASDAQ:ICLR) (ISIN:IE0005711209) - Business Wire 07.20.11 | 06:07 am
- ICON Shareholders Vote In Favour Of All Resolutions At Its Annual General Meeting - Business Wire 07.19.11 | 10:07 am
- ICON Acquires Firecrest Clinical - Business Wire 07.14.11 | 07:07 am
Partner Headlines for ICLR
- Market Roundup - Benzinga 12.27.11 | 01:12 pm
- China Biotech Week In Review: Simcere, BMS Add Cardiovascular Drug To Partnership - Seeking Alpha 12.18.11 | 08:12 am
- Bearish MACD for ICLR - Tale of the Tape - Zacks 12.07.11 | 10:12 am
- 9 Of Richard F. Aster's Q2 Stock Holdings - Seeking Alpha 09.06.11 | 09:09 am
- Contract Research (CROs): On the Brink of Recovery - Seeking Alpha 04.15.11 | 07:04 am
- Zacks #5 Rank Additions for Tuesday - Tale of the Tape - Zacks 03.01.11 | 09:03 am
- MDU RESOURCES (MDU) - Profit Tracks - Zacks 12.14.10 | 01:12 am
- Reviewing the Year-to-Date Performance of Irish ADRs - Seeking Alpha 11.26.10 | 11:11 am
- Cramer's Mad Money - The Sun Sets on First Solar (11/16/10) - Seeking Alpha 11.17.10 | 07:11 am
- ICON Receives ‘Buy’ Rating (GS, ICLR, PPDI) - Benzinga 06.16.10 | 04:06 pm
